In muscle, hexokinase II (HK2) regulates phosphorylation of glucose to glucose 6-phosphate, which has been reported to be impaired in patients with non-insulin-dependent diabetes mellitus (NIDDM). Here we report decreased HK2 enzyme activity in skeletal muscle biopsies from patients with impaired glucose tolerance compared with healthy control subjects (2.7 + 0.9 vs 4.9 + 1.1 nmolmin-l.mg protein-i). Therefore, mutations in the HK2 gene could contribute to skeletal muscle insulin resistance in NIDDM. To address this question, we first determined the exon-intron structure of the human HK2 gene and using this information, we screened all 18 exons with single-strand conformation polymorphism technique in 80 Finnish NIDDM patients. Nine nucle0tide substitutions were found, one of which was a missense mutation (Gtn142-His 142) in exon 4. In human muscle, a single HK2 mRNA transcript with a size of approximately 5500 nucleotides was detected with Northern blot analysis. We also describe an HK2 pseudogene (HK2P1), which was mapped to chromosome 4, band q26, by fluorescence m situ hybridization to metaphase chromosomes. The clinical characteristics and HK2 enzyme activities of the subjects with either Gln or His at residue 142 did not differ from each other. Instead, HK2 activity correlated inversely with fasting blood glucose levels, suggesting that changes in HK2 activity could be secondary to other metabolic abnormalities (r --0.55; p < 0.0003: n = 39). In conclusion; the data suggest that impaired HK2 activity in prediabetic individuals is a consequence of impaired glucose tolerance rather than of a genetic abnormality. The data thus seem to rule out mutations in the HK2 gene as a major cause of inherited insulin resistance in NIDDM. [Diabetologia (1995[Diabetologia ( ) 38: 1466[Diabetologia ( -1474 
resistance in muscle is a typical feature of NIDDM [6] . The molecular basis of insulin resistance is unclear but decreased levels of glucose 6-phosphate in muscle tissue of insulin-resistant subjects suggest that mutations in the HK2 gene, which affect its activity or expression, might contribute to the development of insulin resistance and diabetes mellitus [7] . We have previously localized HK2 to chromosome band 2p13 [8] and shown that HK2 is not linked to MODY [9, 10] . However, these studies did not exclude a role for HK2 in the development of the more common late-onset form(s) of NIDDM which is probably oligo-or polygenic in origin with variation in several different genes contributing to diabetes susceptibility. To address this question, we isolated the HK2 gene and screened all 18 exons for mutations in 80 unrelated Finnish NIDDM subjects who had documented insulin resistance. Furthermore we measured HK enzyme activities in muscle biopsies from prediabetic insulin-resistant individuals and related them to polymorphic variants in the HK2 gene.
Subjects materials and methods
Subjects. Eighty (39 male/41 female) Finnish unrelated NIDDM patients were included in the primary mutation screening of the HK2 gene. An additional 55 control subjects (23 male/32 female) from the same region were used in the evaluation of the allele frequencies. A standard (75 g) oral glucose tolerance test was performed in all subjects. The NIDDM patients were selected from a large cohort of NIDDM patients (the Botnia study) to fulfill the following criteria of insulin resistance: body mass index (BMI) > 27 kg/m 2, fasting serum insulin > 90 pmol/1 or insulin resistance determined by a euglycaemic insulin clamp [6] . The clinical characteristics (mean • SD) of the NIDDM patients and control subjects were as follows: age (67 • 10 and 52 + 13 years), fasting blood glucose levels (9.1+2.9 and 4.9+0.5mmol/1), fasting insulin levels (133 + 120 and 53 + 28 pmol/1), 2-h insulin levels (504 + 310 and 259 + 137 pmol/1), HbA 1 (8. Hexokinase enzyme activities were measured from muscle biopsies taken from 41 Swedish male subjects (10 control subjects and 29 patients with impaired glucose tolerance [IGT]) after a 2-h euglycaemic hyperinsulinaemic clamp. Clinical Parameters of these subjects are shown in Table 1 .
Isolation and characterization of HK2 cDNA and genomic clones. HK2 cDNA clones were isolated by hybridization from a human muscle cDNA library (Clontech, Palo Alto, Calif., USA; cat. no. HL1124A) with a 32p-labelled rat HK2 cDNA probe corresponding to nucleotides 1775-2440. Thirteen clones ()~cHM-1 to -13)were isolated. The 3.2 kilobase (kb) EcoRI insert in )~cHM-11 encoding amino acids 42-917 and T-untranslated region of the mRNA was used to rescreen the same cDNA library and to screen a human genomic library (Stratagene, La Jolla, Calif., USA; cat. no. 943202). Thirty-seven clones 0~cHM-14 to -50) were obtained from the cDNA li- Results are given as mean• a Mann-Whitney test, p < 0.0001. ND, not determined brary and 23 clones ()~gHKG-1 to -23) from the genomic library. The genomic clones were further hybridized with 32p-labelled poly (dA-dC)/(dG-dT) probe (Pharmacia LKB Biotechnology, Piscataway, N.J., USA) to identify those containing CA-repeat rich regions. The insert in cDNA clone )~cHM-39 (aa 1-260) was used to screen a second genomic library (Stratagene, cat. no. 946205) in order to isolate the region of the gene corresponding to exons 1-7, and kgGEN-1 to -22 were isolated. The cDNA and genomic clones were sequenced after subcloning appropriate restriction fragments into pGEM-4Z (Promega, Madison, Wis., USA) using Sequenase version 2.0 (United States Biochemical Corp., Cleveland, Ohio, USA).
Fluorescence in situ chromosomal hybridization. Human cells in metaphase were prepared from phytohaemagglutinin-stimulated peripheral blood lymphocytes. Fluorescence in situ hybridization (FISH) was performed as described previously [11] using biotin-labelled kgHKG-9 which has an insert of approximately 14 kilobase pairs. Hybridization was detected with fluoresce• avidin (Vector Laboratories, Burlingame, Calif., USA) and chromosomes were identified by staining with 4,6-diamidino-2-phenylindole dihydrochloride.
Amplification of simple tandem repeat polymorphisms in HK2 gene and pseudogene. Sequence analysis of the HK2 genomic clone )~gHKG-10 revealed an AT-repeat rich region in intron 13. Two primers, HK-AT1 (5 '-CTAGGCAACATAGGAA-GA CC-3 ') and HK-AT2 (5 '-AAACCTAACATAGTACCT-GGC-3 '), were used to amplify this repeat. The polymerase chain reactions (PCR) were carried out in a volume of 15 ~1 containing 20 ng of genomic DNA, 3 pmol of 32p-labelled HK-AT2, 3 pmol of unlabelled HK-AT1, 200 ~mol/1 dNTR 1.5 retool/1 MgC12, 0.5 units of Taq DNA polymerase (Promega), 16 retool/1 ammonium sulphate, 67 retool/1 Tris-HC1, pH 8.8, and 0.01% Tween-20. The PCR was initiated with denaturation at 94 ~ for 5 min, followed by 30 cycles of denaturation at 94~ for 30 s, annealing at 58~ for 30 s, extension at 72~ for 30 s, and a final extension at 72~ for 10 rain. The PCR products were separated on a 5 % denaturing polyacrylamide 
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). The PCR was carried out in a volume of 15 I~1 using 32p-labelled HKP-1 as described above and 35 cycles of denaturation at 94~ for 30 s, annealing at 57 ~ for 30 s, extension at 72 ~ for 45 s, and a final extension at 72~ for 10 min.
Single-strand conformation polymorphism analysis. Singlestrand conformation polymorphism analysis (SSCP) was performed as described [12] with the following modifications. Table 2 . The PCR products were diluted 1:1 with 20 mmol/1 EDTA (pH 8.0) and 0.2 % sodium dodecyl sulphate (SDS) solution. Before loading on the gel, samples were mixed 1:1 with formamide and heat-denatured at 90 ~ for 5 min. All samples were run on non-denaturing 5 % acrylamide gel (acrylamide/bisacrylamide 60:1) without and with 5 % glycerol. The gels were electrophoresed at 10 W for 8-16 h at room temperature. Samples which had a different migration pattern were further analysed by direct sequencing of the PCR product. The allelic variations of Gln142His mutation were determined by restriction site-generating PCR as previously reported [13] .
RNA blotting. R N A was isolated from a muscle biopsy taken in the basal state from the vastus lateralis muscle of a 32-year-old healthy man. The biopsy specimen was immediately placed into liquid nitrogen and stored at -70 ~ until analysed. Muscle samples were also taken from the hind limb of ad libitum-fed male Sprague-Dawley rats. The human muscle sample (36 mg) and two rat samples (34 and 45 mg) were homogenized in 700 ~tl of ice-cold extraction buffer (4 mol/1 guanidinum thiocyanate, 25 mmol/1 sodium citrate pH 7.0, 1% Nonidet P-40, and 1% ~3-mercaptoethanol). Samples were extracted with phenol and chloroform/isoamyl alcohol (24:1) and ethanol precipitated at -20 ~ for 16 h. Total human (32.2 tzg) and rat (25.5 and 3315 vg) RNAs were fractionated by electrophoresis in a formaldehyde-containing gel [14] . The R N A was transferred to a nitrocellulose membrane (Hoefer Scientific Instruments, San Francisco, Calif., USA), which was hybridized with 32p-labelled insert from the human HK2 cDNA clone, )~cHM-11; the filter was washed in 0.1 x SSC/0.1% SDS at 50 ~ before exposure to X-ray film. heim, Germany). Fluorescence was measured with a fluorometer (Transcon 102 FN analyser; Orion Analytica, Helsinki, Finland) for 15 min. Protein content was assayed in the homogenate according to Lowry et al. [16] , and the enzyme activities expressed as nmol. min -1 9 mg protein -1.
Determination of muscle HK1 and HK2 enzyme activities after 2-h insulin-stimulated clamp.
Muscle biopsies were taken under local anaesthesia with a Bergstr6m needle from the vastus lateralis muscle in 29 IGTand 10 control subjects at the end of a 2-h euglycaemic hyperinsulinaemic clamp (insulin infusion 45 mU. m -2-min q) [15] . Muscle samples were homogenized (10 mg muscle/100 Fd homogenizing reagent: 50 mmol/1 Tris-HC1 pH 7.4, 0.5 mmol/I DTT, i mmol/1 EDTA, and 2 mmol/1 MgCl2) with ground glass homogenizer on ice. Ability to separate HK1 and HK2 enzyme activities is based on different temperature sensitivities of these two isoforms [1] . One sample was kept on ice in order to measure total hexokinase enzyme activity (HK1 + HK2) while the other sample was heated at 45 ~ for 1 h in order to eliminate HK2 enzyme activity. The hexokinase enzyme activities were determined with enzymelinked fluorometric assay. Five microlitre sample homogenate was mixed with 505 F1 assay buffer consisting of 50 mmol/1 Tris-HC1 pH 7.4, 0.02 % bovine serum albumin, 2 retool/1 ATR 5 mmol/1 MgClz, 0.3 mmol/1 NADR 1 mmol/1 EDTA, i mmol/1 DTF, 1 mmol/1 glucose, and 0.14 U/ml glucose 6-phosphate dehydrogenase (Boehringer Mannheim, Mann-
Statistical analysis
Yates' corrected chi-squared (~2) test was used to estimate differences between allele frequencies. Significances of differences between means of clinical parameters were analysed with Student's t-test If the distribution of the parameter was not normal, a nonparametric Mann-Whitney test was used instead: Values ofp < 0.05 were considered to be significant.
Results
Sequence of human HK2 cDNAI The sequence of human HK2 mRNA was deduced from the composite sequences of the inserts in three overlapping clones kcHM-3, kcHM-11 and kcHM-39 (EMBL accession no. Z46 376). RNA blotting studies showed a single transcript of-5500 nucleotides in human muscle (Fig. 1) . The size of rat HK2 mRNA was estimated to the gene is unknown because of gaps of undetermined size in introns 1, 2 and 7. The sequences of the 18 exons were determined (EMBL accession no. Z46604, Z46354-Z46369). The introns interrupt the gene in identical positions to those previously determined for the corresponding rat gene [19] . Exon-intron sequences determined here were identical with previously published results [20, 21] . Fig.3 . Chromosomal localization of HK2P1 by fluorescence in situ hybridization. The hybridization of biotin-labelled kgHKG-9 DNA to normal human cells in metaphase from phytohaemagglutinin-stimulated peripheral blood lymphocytes is shown. The chromosome 4 homologues are identified with arrows. Specific labelling was observed at chromosome band 4q26. The inset shows partial karyotypes of two chromosome 4 homologues illustrating specific labelling at 4q26 (arrowheads). Images were obtained using Zeiss Axiphot microscope coupled to a cooled charge-coupled-device camera. Separate images of 4,6-diamidino-2-phenylindole dihydrochloride DAPI-stained chromosomes and the hybridization signal were merged using image analysis software (NU200 and Imagel.52b)
Isolation and chromosomal localization of an HK2
pseudogene. The sequence of the insert in the genomic clone ~gHKG-9 (EMBL accession no. Z46 370) was 96 % identical to exons 1-7 of HK2. In contrast to HK2, this sequence was not interrupted by introns suggesting that kgHKG-9 corresponded to a HK2-pseudogene, designated HK2P1. The chromosomal localization of the HK2P1 was determined by hybridization of biotin-labelled kgHKG-9 DNA to normal human chromosomes in metaphase. The FISH results showed specific labelling of chromosome 4 ( Fig. 3) and of the X chromosome. Specific labelling of 4q26-q28 was observed on four (eight cells), three (nine ceils), or two (8 cells) chromatids of the chromosome 4 homologues in 25 cells examined. Of the 103 signals observed (75 of 100 4q chromatids from 25 cells in metaphase were labelled), 62 (60%) signals were located at 4q26, and 13 (13 %) were at 4@8. Fourteen signals (13.5 %) were located at Xq21.1, three single signals were located at 11p12, and the remaining 11 single signals were localized to other random chromosomal sites. Specific signals were also observed at 4q26-q28 in a second FISH experiment using this same probe; 42 of 45 signals observed in 18 cells were located at 4q26-q28. Hybridization of the probe to Xq21.1 was not observed in this experiment. The results of FISH analysis suggest that HK2P1 is located at 4q26. b e -5300 nucleotides which agrees well with previous estimates of -5200 nucleotides [17] .
Our human HK2 m R N A sequence is similar to that previously reported by Deeb et al. [18] with the following differences (published/our sequence): Ser12 (TCG)/Thr12 (ACG); Glul06 (GAA)/Glul06 (GAG); Arg405 (CGC)/Arg405 (CGG); Ala406 (GCT)/Leu406 (CTG); Ala634 (GCG)/Va1634 (GTG); Asn692 (AAT)/Asn692 (AAC); Ala711 (GCA)/Ala711 (GCC); Leu766 (CTG)/Leu766 (CTA); and ile803 (ATC)/Thr803 (ACC). The studies described below indicate that the silent mutations in the codons for Asn692 and Leu766 are common polymorphisms; the basis for the other sequence differences (i. e. sequence or cloning errors) is unknown.
Isolation and characterization of the human HK2
gene. HK2 was isolated as a series of overlapping clones in lambda phage. The gene consists of 18 exons that span more than 50 kb (Fig.2) ; the actual size of Characterization of STRPs in HK2 gene and pseudogene. Sequence analysis of the HK2 clone gHKG-10 revealed an STRP of the form (AT)n (EMBL accession no. Z46377) in intron 13 approximately 500 base pairs (bp) downstream from exon 12 (HKAT in Fig. 2) . In an analysis of 42 unrelated healthy non-diabetic Finnish subjects, this STRP showed 17 alleles and polymorphism information content of 0.79 ( Table 3 ). An STRP of the form (CA)n (EMBL accession no. Z46378) was identified in the HK2P1 clone kgHKG-9. Twenty alleles were noted on typing 42 unrelated subjects (Table 3) . These STRPs could be useful in genetic linkage studies of these loci in diabetes mellitus and other disorders.
Screening of HK2 for mutations in subjects with
NIDDM. SSCP was used to screen HK2 for mutations in a group of 80 unrelated insulin-resistant Finnish subjects with NIDDM (Fig. 4) . Two different gel conditions were used: 5 % non-denaturing polyacry- Table 5) .
HK1 and HK2 enzyme activities in muscle. The IGT and control groups were matched for age and BMI. The IGT patients had significantly lower total hexokinase activity than the control subjects, which was due to a reduction in both HK1 and HK2 activities (Table 1) . Total hexokinase (6.2 + 0.8 vs 5.3 + 0.9 nmol 9 kg -1 -mg protein-I; p = 0.015) and HK2 (2.9 0.9 vs. 2.3 _+ 0.7 nmol. kg -1 protein-i; p = 0.051) activities were slightly higher in IGT patients with than those without a first-degree family history of NIDDM. To examine whether the Gln142His polymorphism has an influence on hexokinase enzyme activity in muscle, we measured the muscle HK2 enzyme activity in 28 IGT patients and subdivided them into two groups according to the genotypic variants (Gln/Gln = 1,and Gln/His, His/His --2). As seen Results are given as mean + SD f r o m T a b l e 6, t h e r e w a s n o d i f f e r e n c e in h e x o k i n a s e e n z y m e a c t i v i t i e s b e t w e e n t h e s e g r o u p s s u g g e s t i n g t h a t this c o d o n 142 p o l y m o r p h i s m is u n l i k e l y to h a v e a n e f f e c t t o t h e H K 2 e n z y m e a c t i v i t y in m u s c l e . O f n o t e , t o t a l h e x o k i n a s e (r = 0.52; p < 0.0001) a n d H K 2 (r = 0.55; p < 0.0003) e n z y m e a c t i v i t i e s c o r r e l a t e d inv e r s e l y w i t h t h e f a s t i n g b l o o d g l u c o s e c o n c e n t r a t i o n (Fig. 5) . T h e r e was, h o w e v e r , n o c o r r e l a t i o n b e t w e e n t h e h e x o k i n a s e a c t i v i t i e s a n d t h e M -v a l u e ( i n s u l i n s t i m u l a t e d g l u c o s e u p t a k e ) m e a s u r e d d u r i n g t h e c l a m p . 
Discussion
Insulin resistance represents an early, probably inherited defect in NIDDM, which can be seen in normoglycaemic offspring of NIDDM parents [15] . Although the molecular causes of insulin resistance are not known, two recent studies have indicated a defect in the enzyme which catalyses phosphorylation of glucose to glucose 6-phosphate i. e. the HK2 step [7, 22] . We have now provided evidence that the insulin-stimulated HK2 activity is decreased in insulin-resistant individuals with IGT. It remains to be ascertained whether a defect in the HK2 gene causes insulin resistance in NIDDM.
As a first step towards answering this question we determined the exon-intron organization of the human HK2 gene, thereby making SSCP scanning of 1473 this gene for mutations possible. In human skeletal muscle, the HK2 mRNAwas found to be a single transcript with an estimated length of -5500 nucleotides. In rats HK2 mRNA was -5300 nucleotides in length, which agrees well with previous estimates of-5200 nucleotides [17] . While this manuscript was in preparation, Malkki et al. [20] and Printz et al. [21] reported the cloning and exon-intron organization of the human HK2 gene. Their results describing the structure of HK2 are identical to those presented here.
SSCP scanning of all 18 exons of HK2 gene in 80 unrelated NIDDM patients revealed nine nucleotide substitutions, of which five have been reported recently [13, 23, 24] . In addition, we found two new polymorphisms in the 5 '-untranslated region and two silent polymorphisms in the coding region of the HK2 gene. In keeping with previous reports [13, 23, 24] , we found a missense mutation Glnt42His exon 4. The allele frequencies of this amino acid substitution did not differ between NIDDM and control subjects. All NIDDM patients were obese and had high insulin levels indicating insulin resistance. In addition, insulin resistance had been confirmed by a euglycaemic insulin clamp in one-third of the patients. The insulin values in the individuals with genotypes Gln/Gln, Gln/His and His/His in position 142 did not differ, it is therefore unlikely that this amino acid contributes to the development of the insulin resistance in these NIDDM patients. However, in patients with manifest NIDDM, insulin resistance can be the consequence of glucose toxicity (metabolic insulin resistance) as well as of a genetic defect [25] . To partially circumvent this problem, we studied an additional group of non-diabetic subjects, measuring hexokinase activity in skeletal muscle biopsies taken at the end of a euglycaemic clamp. Despite similar age and degree of obesity, the IGT subjects had significantly decreased hexokinase activity. Nevertheless, our data do not support the view that insulin resistance in the IGT subjects is the consequence of a genetic defect in the HK2 gene. First, if anything, hexokinase activity was higher in the IGT subjects with, than those without, a first-degree family history of NIDDM. This could represent a mechanism to compensate for a defect distal to the phosphorylation step. Second, the hexokinase enzyme activities did not differ between individuals with Gln 142 or His 142 alleles. Third, the hexokinase activity showed a strong inverse correlation with the fasting glucose concentrations, suggesting that the decrease in the hexokinase activity could be a consequence of the metabolic derangement rather than of a genetic abnormality.
In conclusion, the data suggest that decreased hexokinase activity in prediabetic insulin-resistant individuals is secondary to glucose intolerance rather than to genetic alterations in the HK2 gene. It is thus unlikely that the HK2 gene represents a major cause of inherited insulin resistance in NIDDM.
